Clinical Trials Search
Title |
Intervention | NCT ID | Sponsor |
|---|---|---|---|
| Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts | Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment, Questionnaire Administration | NCT02933489 | ECOG-ACRIN Cancer Research Group |
| Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer | Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention | NCT00983580 | National Cancer Institute (NCI) |
| Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules | Aspirin, Laboratory Biomarker Analysis, Placebo | NCT02169271 | National Cancer Institute (NCI) |
| ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing... | Laboratory Biomarker Analysis, Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet, Pharmacological Study, Placebo | NCT02917629 | National Cancer Institute (NCI) |
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | Real Acupressure Band, Placebo Acupressure Band | NCT01346267 | University of South Florida |
| Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer | Acupuncture | NCT01141231 | M.D. Anderson Cancer Center |
| Adaptation of Individual Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients | In-depth Patient Interviews, Adaptation of IMCP for Chinese Immigrant Cancer Patients | NCT02112188 | Memorial Sloan Kettering Cancer Center |
| Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast | Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration | NCT03063619 | M.D. Anderson Cancer Center |
| Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... | Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery | NCT02598557 | National Cancer Institute (NCI) |
| Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and... | Olanzapine, Chemotherapy (cisplatin or cyclophosphamide and doxorubicin), Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant), Placebo | NCT02116530 | Alliance for Clinical Trials in Oncology |